The FDA has granted approval to Elon Musk’s brain implant company, NeuraLink, to carry out clinical studies on humans.
“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” tweeted the official account of NeuraLink on Thursday afternoon.
Musk has long been predicting that the FDA would eventually allow the brain implant company to carry out studies involving humans.